How Corporations Corrupt Science at the Public's Expense: Report looks at methods of corporate abuse, suggests steps toward reform [Full Report (PDF)] [Executive Summary (PDF)] [more inside]
Feast your senses (including, perhaps, your sense of outrage) on this Merck Vioxx sales training video, presented in 3 parts without commercial interruption (heh) by the often interesting Pharmalot. [more inside]
The number of patient fatalities in mifepristone abortions is estimated at 1 in 200,0001, about double the rate for suction-aspiration abortions of comparable terms, and about equal to the combined early and late term fatality rates for vacuum aspiration abortion.2 (source) (via) [More inside]
No mere slap on the wrist for Merck. Jury awards grieving widow $253.4 Mil in Vioxx suit. The first of thousands of cases like it. (washpost)
In September 2001 the FDA warned Merck, makers of the painkiller Vioxx, for engaging in a promotional campaign that minimized "potentially serious cardiovascular findings." The previous year, Merck spent $161 million on Vioxx advertising (more than Pepsi or Budweiser spent on advertising that year). Earlier this year, a securities class action complaint was filed on behalf of several Merck investors alleging the company engaged in a marketing campaign that included false and misleading statements concerning the safety profile of Vioxx and that company insiders sold personally held shares of Merck for over $175 million in proceeds. Today, Merck withdrew Vioxx from the market.